Molecular Pharmacology: 36 (3)

September 01, 1989; Volume 36,Issue 3

You have access
Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.
R B Clark, J Friedman, R A Dixon and C D Strader

Molecular Pharmacology September 1989, 36 (3) 343-348;
You have access
Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action.
S N Abramson, Z Radic, D Manker, D J Faulkner and P Taylor

Molecular Pharmacology September 1989, 36 (3) 349-354;
You have access
ATP-sensitive binding of melittin to the catalytic domain of protein kinase C.
C A O'Brian and N E Ward

Molecular Pharmacology September 1989, 36 (3) 355-359;
You have access
1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells.
B Goz, P L Carl and T D Tlsty

Molecular Pharmacology September 1989, 36 (3) 360-365;
You have access
Binding of vinblastine to stabilized microtubules.
W D Singer, M A Jordan, L Wilson and R H Himes

Molecular Pharmacology September 1989, 36 (3) 366-370;
You have access
Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
Y H Hsiang, J B Jiang and L F Liu

Molecular Pharmacology September 1989, 36 (3) 371-376;
You have access
Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
L M Bornheim and M A Correia

Molecular Pharmacology September 1989, 36 (3) 377-383;
You have access
Desensitization uncouples the formyl peptide receptor-guanine nucleotide-binding protein interaction in HL60 cells.
K R McLeish, P Gierschik and K H Jakobs

Molecular Pharmacology September 1989, 36 (3) 384-390;
You have access
Inositol tetrakisphosphate mobilizes calcium from cerebellum microsomes.
S K Joseph, C A Hansen and J R Williamson

Molecular Pharmacology September 1989, 36 (3) 391-397;
You have access
Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat.
J K Nicholson, D P Higham, J A Timbrell and P J Sadler

Molecular Pharmacology September 1989, 36 (3) 398-404;
You have access
Determination of the association and dissociation rate constants of muscarinic antagonists on rat pancreas: rank order of potency varies with time.
M Waelbroeck, J Camus and J Christophe

Molecular Pharmacology September 1989, 36 (3) 405-411;
You have access
Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.
E Leung and R D Green

Molecular Pharmacology September 1989, 36 (3) 412-419;
You have access
Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
D R Poyner, N J Birdsall, C Curtis, P Eveleigh, E C Hulme, E K Pedder and M Wheatley

Molecular Pharmacology September 1989, 36 (3) 420-429;
You have access
Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
N W Kleckner and R Dingledine

Molecular Pharmacology September 1989, 36 (3) 430-436;
You have access
Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
D Stickle and R Barber

Molecular Pharmacology September 1989, 36 (3) 437-445;
You have access
Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.
K A Neve, R A Henningsen, J R Bunzow and O Civelli

Molecular Pharmacology September 1989, 36 (3) 446-451;
You have access
Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles.
R Kaufman, G A Rogers, C Fehlmann and S M Parsons

Molecular Pharmacology September 1989, 36 (3) 452-458;
You have access
Growth of S49 cells in low concentrations of beta-adrenergic agonists causes desensitization.
R Barber, T J Goka and R W Butcher

Molecular Pharmacology September 1989, 36 (3) 459-464;
You have access
An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
J Baumgold and A Drobnick

Molecular Pharmacology September 1989, 36 (3) 465-470;
You have access
Effect of anesthetics on calcium stores and membrane order of brain microsomes.
L C Daniell and R A Harris

Molecular Pharmacology September 1989, 36 (3) 471-477;
You have access
Ceftriaxone binding to human serum albumin: competition with bilirubin.
R Brodersen and A Robertson

Molecular Pharmacology September 1989, 36 (3) 478-483;
You have access
Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
M K Bijsterbosch, G J Ziere and T J Van Berkel

Molecular Pharmacology September 1989, 36 (3) 484-489;
You have access
Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
M Hasobe, J G McKee, H Ishii, M Cools, R T Borchardt and E De Clercq

Molecular Pharmacology September 1989, 36 (3) 490-496;
You have access
Enantioselective N-oxygenation of verapamil by the hepatic flavin-containing monooxygenase.
J R Cashman

Molecular Pharmacology September 1989, 36 (3) 497-503;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals